Cardiac diagnostics and monitoring
Clinical evidence
View clinical evidence on continuous cardiac monitoring.
The LINQ™ family of ICMs (Reveal LINQ™ ICM and LINQ II™ ICM) has been featured in 1,000+ published clinical articles and abstracts.
Read a large, real-world cohort analysis of arrhythmia detection and therapeutic interventions in patients with insertable cardiac monitors2.
Read about how the CRYSTAL-AF study showed that the Reveal LINQ™ ICM is superior to standard monitoring for atrial fibrillation (AF) detection in cryptogenic stroke patients.
Review the STROKE AF study that showed that the Reveal LINQ™ ICM is superior to site-specific usual care for AF detection in large- and small-vessel stroke patients.
Learn about the clinical impact of this study, which evaluated Reveal™ ICM use in patients with unexplained syncope.
Explore the results of this study, which evaluated continuous, long-term monitoring with Reveal LINQ™ ICM for patients at high risk for AF and stroke.
We do not review or control the content of external sites and are not responsible for any interactions or transactions that may occur there. Any product availability and regulatory requirements on the destination site may differ depending on your location. When you continue, the terms of use and privacy statement of the external site will apply.
Product availability and regulatory requirements may differ depending on your location. The destination website is governed by the laws and regulations of the country in which it operates, which may be different from those in your country. When you continue, the terms of use and privacy statement of the destination Medtronic site will apply.